NCT07081230 Comparison Between the Efficacy of Albumin Versus Hyaluronic Acid Scaffold in Combination With Concentrated Growth Factors as an Adjunct to Non-surgical Treatment of Periodontitis
| NCT ID | NCT07081230 |
| Status | Recruiting |
| Phase | — |
| Sponsor | husain abduljalil alam |
| Condition | Periodontitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-07-07 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-07-07 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is to clinically evaluate the efficacy of albumin versus hyaluronic acid scaffolds in combination with concentrated growth factors in the non- surgical treatment of stage II/III periodontitis. The secondary objective is to evaluate the duration and concentration of different growth factors release in the gingival crevicular fluid.
Eligibility Criteria
ii) Inclusion Criteria: * Patients aging from 25-45 years * Patients with stage II /III periodontitis * Systemically free iii) Exclusion Criteria: * Any systemic condition that may impact the study (21) * Poor oral hygiene * Pregnant and breastfeeding women * Smoking patients. * Patients received periodontal treatment in the last 6 months * Unable to comply with study protocol
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07081230 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 45 Years, studying Periodontitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07081230 currently recruiting?
Yes, NCT07081230 is actively recruiting participants. Contact the research team at hussainalam@std.mans.edu.eg for enrollment information.
Where is the NCT07081230 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07081230 clinical trial?
NCT07081230 is sponsored by husain abduljalil alam. The trial plans to enroll 30 participants.